SEARCH

SEARCH BY CITATION

References

  • 1
    Spinelli KS; Fromwiller TE, Daniel RA, Kiely JM, Nakeeb A, Komorowski RA, Wilson SD, Pitt HA. Cystic pancreatic neoplasms: observe or operate. Ann Surg. May 2004; 239(5): 651657; discussion 657–659.
  • 2
    Laffan TA, Horton KM, Klein AP, Berlanstein B, Siegelman SS, Kawamoto S, Johnson PT, Fish-man EK, Hruban RH. Prevalence of unsuspected pancreatic cysts on MDCT. AJR Am J Roentgenol. Sep 2008; 191 (3): 802807.
  • 3
    Winter JM, Cameron JL, Lillemoe KD, Campbell KA, Chang D, RiaII TS, Coleman J, Sauter PK, Canto M, Hruban RH, et al. Periampullaiy and pancreatic incidentaloma: a single institution's experience with an increasingly common diagnosis. Ann Surg. May 2006; 243(5): 673680; discussion 680–673.
  • 4
    Zhang XM, Mitchell DG, Dohke M, Holland GA, Parker L. Pancreatic cysts: depiction on single-shot fast spin-echo MR images. Radiology. May 2002; 223(2): 547553.
  • 5
    Lahat G, Haim M Ben, Nachmany I, Sever R, Blachar A, Nakache R, Klausner JM. Pancreatic incidentalomas: high rate of potentially malignant tumors. J Am Coll Surg. Sep 2009; 209(3): 313319.
  • 6
    Pitman MB, Lewandrowski K, Shen J, Sahani D, Brugge W, Fernandez-del Castillo C. Pancreatic cysts: preoperative diagnosis and clinical management. Cancer Cytopathol. Feb 25 2010; 118(1): 113.
  • 7
    Khalid A, Zahid M, Finkelstein SD, LeBlanc JK, Kaushik N, Ahmad N, Brugge WR, Edmundowicz SA, Hawes RH, McGrath KM. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study. Gastrointesl Endose. May 2009; 69(6): 10951102.
  • 8
    Shen J, Brugge WR, Dimaio CJ, Pitman MB. Molecular analysis of pancreatic cyst fluid: a comparative analysis with current practice of diagnosis. Cancer Cytopathol. Jun 25 2009; 117(3): 217227.
  • 9
    Yoshizawa K, Nagai H, Sakurai S, Hironaka M, Morinaga S, Saitoh K, Fukayama M. Clonality and K-ras mutation analyses of epithelia in intraductal papillary mucinous tumor and mucinous cystic tumor of the pancreas. Virchows Arch. Nov 2002; 441 (5): 437443.
  • 10
    Izeradjene K, Combs C, Best M, Gopinathan A, Wagner A, Grady WM, Deng CX, Hruban RH, Adsay NV, Tuveson DA, et al. Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas. Cancer Cell. Mar 2007; 11(3): 229243.
  • 11
    Jimenez RE, Warshaw AL, Z'Graggen K, Hartwig W, Taylor DZ, Compton CC, Fernandez-del Castillo C. Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy. Ann Surg. Oct 1999; 230(4): 501509; discussion 509–511.
  • 12
    Gerdes B, Wild A, Wittenberg J, Barth P, Ramaswamy A, Kersting M, Luttges J, Kloppel G, Bartsch DK. Tumor-suppressing pathways in cystic pancreatic tumors. Pancreas. Jan 2003; 26(1): 4248.
  • 13
    Biankin AV, Biankin SA, Kench JG, Morey AL, Lee CS, Head DR, Eckstein RP, Hugh TB, Henshall SM, Sutherland RL. Aberrant p16(INK4A) and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma. Gut. Jun 2002; 50(6): 861868.
  • 14
    Hruban RH, Adsay NV, Albores-Saavedra J, Anver MR, Biankin AV, Boivin GP, Furth EE, Furukawa T, Klein A, Klimstra DS, et al. Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. Cancer Res. Jan 1 2006; 66(1): 95106.
  • 15
    Mei R, Galipeau PC, Prass C, Berno A, Ghandour G, Patil N, Wolff RK, Chee MS, Reid BJ, Lockhart DJ. Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays. Genome Res. Aug 2000; 10(8): 11261137.
  • 16
    Schoedel KE, Finkelstein SD, Ohori NP. K-ras and microsatellite marker analysis of fine-needle aspirates from intraductal papillary mucinous neoplasms of the pancreas. Diagn Cytopathol. Sep 2006; 34(9): 605608.
  • 17
    Sawhney MS, Devarajan S, O'Farrel P, Cury MS, Kundu R, Vollmer CM, Brown A, Chuttani R, Pleskow DK. Comparison of carcinoembryonic antigen and molecular analysis in pancreatic cyst fluid. Gastrointest Endosc. May 2009; 69(6): 11061110.
  • 18
    Khalid A, McGrath KM, Zahid M, Wilson M, Brody D, Swalsky P, Moser AJ, Lee KK, Slivka A, Whitcomb DC, et al. The role of pancreatic cyst fluid molecular analysis in predicting cyst pathology. Clin Gastroenterol Hepatol. Oct 2005; 3(10): 967973.
  • 19
    Sreenarasimhaiah J, Lara LF, Jazrawi SF, Barnett CC, Tang SJ. A comparative analysis of pancreas cyst fluid CEA and histology with DNA mutational analysis in the detection of mucin producing or malignant cysts. JOP. 2009; 10(2): 163168.
  • 20
    Brugge WR, Lauwers GY, Sahani D, Fernandez-del Castillo C, Warshaw AL. Cystic neoplasms of the pancreas. N Engl J Med. Sep 16 2004; 351(12): 12181226.
  • 21
    Scheiman JM. Cystic lesion of the pancreas. Gastroenterology. Feb 2005; 128(2): 463469.
  • 22
    Warshaw AL, Compton CC, Lewandrowski K, Cardenosa G, Mueller PR. Cystic tumors of the pancreas. New clinical, radiologic, and pathologic observations in 67 patients. Ann Surg. Oct 1990; 212(4): 432443; discussion 444–435.
  • 23
    Curry CA, Eng J, Horton KM, Urban B, Siegelman S, Kuszyk BS, Fishman EK. CT of primary cystic pancreatic neoplasms: can CT be used for patient triage and treatment? AJR Am J Roentgenol. Jul 2000; 175(1): 99103.
  • 24
    Koito K, Namieno T, Ichimura T, Yama N, Hareyama M, Morita K, Nishi M. Mucin-producing pancreatic tumors: comparison of MR cholangiopancreatography with endoscopic retrograde cholangiopancreatography. Radiology. Jul 1998; 208(1): 231237.
  • 25
    Brugge WR, Lewandrowski K, Lee-Lewandrowski E, Centeno BA, Szydlo T, Regan S, del Castillo CF, Warshaw AL. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology. May 2004; 126(5): 13301336.
  • 26
    O'Toole D, Palazzo L, Hammel P, Yaghlene L Ben, Couvelard A, Felce-Dachez M, Fabre M, Dancour A, Aubert A, Sauvanet A, et al. Macrocystic pancreatic cystadenoma: the role of EUS and cyst fluid analysis in distinguishing mucinous and serous lesions. Gastrointest Endosc. Jun 2004; 59(7): 823829.
  • 27
    Pitman MB, Michaels PJ, Deshpande V, Brugge WR, Bounds BC. Cytological and cyst fluid analysis of small (<or= 3 cm) branch duct intraductal papillary mucinous neoplasms adds value to patient management decisions. Pancreatology. 2008; 8(3): 277284.
  • 28
    Sperti C, Pasquali C, Guolo P, Polverosi R, Liessi G, Pedrazzoli S. Serum tumor markers and cyst fluid analysis are useful for the diagnosis of pancreatic cystic tumors. Cancer. Jul 15 1996; 78(2): 237243.
  • 29
    Sperti C, Pasquali C, Pedrazzoli S, Guolo P, Liessi G. Expression of mucin-like carcinoma-associated antigen in the cyst fluid differentiates mucinous from nonmucinous pancreatic cysts. Am J Gastroenterol. Apr 1997; 92(4): 672675.
  • 30
    Cuoghi A, Farina A, Z'Graggen K, Dumonceau JM, Tomasi A, Hochstrasser DF, Genevay M, Lescuyer P, Frossard JL. Role of proteomics to differentiate between benign and potentially malignant pancreatic cysts. J Proteome Res. May 6 2011; 10(5): 26642670.
  • 31
    Ke E, Patel BB, Liu T, Li XM, Haluszka O, Hoffman JP, Ehya H, Young NA, Watson JC, Weinberg DS, et al. Proteomic analyses of pancreatic cyst fluids. Pancreas. Mar 2009; 38(2):e33e42.
  • 32
    Maker AV, Katabi N, Qin LX, Klimstra DS, Schattner M, Brennan MF, Jarnagin WR, Allen PJ. Cyst fluid interleukin-1beta (IL1beta) levels predict the risk of carcinoma in intraductal papillary mucinous neoplasms of the pancreas. Clin Cancer Res. Mar 15 2011; 17(6): 15021508.
  • 33
    Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, Yamaguchi K, Yamao K, Matsuno S. International consensus guidelines for management of intraductalpapillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006, 6(1-2): 1732.